Last updated on November 2019

A Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of SEP 363856 in Subjects With Parkinson's Disease Psychosis


Brief description of study

A study to evaluate the safety and tolerability of SEP363856 in subjects with Parkinson's Disease Psychosis.

 

Clinical Study Identifier: TX212739

Find a site near you

Start Over